# Feasibility Trial Testing the Bionic Pancreas With ZP4207

> **NCT02971228** · PHASE2 · COMPLETED · sponsor: **Zealand Pharma** · enrollment: 13 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Insulin Lispro
- **DRUG:** ZP4207 (dasiglucagon)
- **DRUG:** Glucagon
- **DEVICE:** iPhone-based bionic pancreas
- **DEVICE:** iLet-based bionic pancreas

## Key facts

- **NCT ID:** NCT02971228
- **Lead sponsor:** Zealand Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-05-24
- **Final completion:** 2017-06-07
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2021-03-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02971228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02971228, "Feasibility Trial Testing the Bionic Pancreas With ZP4207". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02971228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*